• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Silver Spike Acquisition Corp II (Amendment)

    2/10/23 4:30:16 PM ET
    $SPKB
    Blank Checks
    Finance
    Get the next $SPKB alert in real time by email
    SC 13G/A 1 p23-0247sc13ga.htm SILVER SPIKE ACQUISITION CORP. II

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
    SCHEDULE 13G/A
     
    Under the Securities Exchange Act of 1934
    (Amendment No. 2)*
     

    Silver Spike Acquisition Corp. II

    (Name of Issuer)
     

    Class A Ordinary Shares, par value $0.0001 per share

    (Title of Class of Securities)
     

    G8201H105

    (CUSIP Number)
     

    December 31, 2022

    (Date of Event Which Requires Filing of this Statement)
     
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
     
    ¨ Rule 13d-1(b)
    ý Rule 13d-1(c)
    ¨ Rule 13d-1(d)
     
    (Page 1 of 6 Pages)

    ______________________________

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    This Amendment No. 2 on Schedule 13G/A corrects a clerical error in the filing made by the Reporting Persons on February 14, 2022, which was inadvertently filed as an original 13G despite it being an amendment to the original Schedule 13G filed on March 22, 2021.

     

    CUSIP No. G8201H10513G/APage 2 of 6 Pages

     

    1

    NAMES OF REPORTING PERSONS

    Candlestick Capital Management LP

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware, USA

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    0

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    0

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    0%

    12

    TYPE OF REPORTING PERSON

    IA

             

     

     

    CUSIP No. G8201H10513G/APage 3 of 6 Pages

     

     

    1

    NAMES OF REPORTING PERSONS

    Candlestick Master Fund LP

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Cayman Islands

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    0

    6

    SHARED VOTING POWER

    0

    7

    SOLE DISPOSITIVE POWER

    0

    8

    SHARED DISPOSITIVE POWER

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    0

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    0%

    12

    TYPE OF REPORTING PERSON

    PN

             

     

     

    CUSIP No. G8201H10513G/APage 4 of 6 Pages

     

     

    Item 1(a). Name of Issuer
       
      Silver Spike Acquisition Corp II (the “Issuer”)
       
    Item 1(b). Address of Issuer’s Principal Executive Offices
       
      600 Madison Avenue 17th Floor, New York, New York 10022

     

    Item 2(a, b, c). Names of Person Filing, Address of Principal Business Office, Citizenship:
       
      This report on Schedule 13G is being filed by Candlestick Capital Management LP, a Delaware limited partnership (the “Firm”), and Candlestick Master Fund LP, a Cayman Islands exempted limited partnership (“Candlestick Master”). The address for the Firm and Candlestick Master is: 1 Lafayette Place, Greenwich, Connecticut 06830.
       
    Item 2(d). Title of Class of Securities
       
      Class A Ordinary Shares, par value $0.0001 per share (the “Class A Ordinary Shares”),
       
    Item 2(e). CUSIP No.:
       
      G8201H105

     

    Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person filing is a:
       
      N/A

     

    Item 4. Ownership
       
      Information with respect to the Firm’s and Candlestick Master’s ownership of securities of the Issuer is incorporated by reference to items (5) - (9) and (11) of the respective cover page of the Firm and Candlestick Master.

     

    Item 5. Ownership of Five Percent or Less of a Class
       
      If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [x].

     

     

    CUSIP No. G8201H10513G/APage 5 of 6 Pages

     

     

    Item 6. Ownership of More Than Five Percent on Behalf of Another Person
       
      Not Applicable.
       
    Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person
       
      Not Applicable.
       
    Item 8. Identification and Classification of Members of the Group
       
      Not Applicable.
       
    Item 9. Notice of Dissolution of Group
       
      Not Applicable.
       
    Item 10. Certification
       
      By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

    CUSIP No. G8201H10513G/APage 6 of 6 Pages

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct.

     

    Dated: February 10, 2023

     

     

      Candlestick Capital Management LP

     

      By: /s/ James McGovern
        James McGovern, Chief
        Compliance Officer

     

      Candlestick Master Fund LP

     

      By: /s/ James McGovern
        James McGovern,
        Chief Compliance Officer
       

     

     

    Get the next $SPKB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SPKB

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SPKB
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Silver Spike Acquisition Corp II Announces Redemption of Class A Ordinary Shares

    NEW YORK, March 13, 2023 (GLOBE NEWSWIRE) -- Silver Spike Acquisition Corp II (the "Company") today announced that it will redeem all of its outstanding Class A ordinary shares (the "Class A Ordinary Shares"), effective as of March 27, 2023, because the Company will not consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association (the "Articles"). As stated in the Company's Articles, if the Company does not consummate an initial business combination within 24 months of the closing of the Company's initial public offering, or March 15, 2023, the Company will: (i) cease all operations except for the purpose of

    3/13/23 9:23:35 PM ET
    $SPKB
    Blank Checks
    Finance

    Eleusis and Silver Spike Acquisition Corp. II Mutually Agree to Terminate Business Combination Agreement

    Eleusis, a clinical-stage life science company that aims to unlock the therapeutic potential of psychedelics, and Silver Spike Acquisition Corp. II ("Silver Spike II" or "SPKB") (NASDAQ:SPKB), a publicly traded special purpose acquisition company ("SPAC"), today announced that they have mutually agreed to terminate their previously announced agreement and plan of merger (the "Business Combination Agreement"), effective immediately, as a result of current unfavorable market conditions. Silver Spike II intends to continue in its efforts to identify a prospective target business for an initial business combination. Additional information about the termination of the Business Combination Agre

    6/9/22 4:05:00 PM ET
    $SPKB
    Blank Checks
    Finance

    Eleusis Announces Notice of Allowance for US Patent Application with Claims Covering Lead Drug Candidate ELE-Psilo

    Eleusis Holdings Ltd announced today it has received a Notice of Allowance for its proprietary psilocin salt form and accompanying formulations from the US Patent and Trademark Office. This salt form and formulations are being developed as Eleusis' lead drug candidate, ELE-Psilo. ELE-Psilo is an investigational psychedelic drug candidate designed to deliver psilocybin's active moiety, psilocin, by intravenous administration. Psilocybin is a prodrug found naturally in certain species of fungi that is metabolized into its pharmacologically active form, psilocin. Eleusis is developing its proprietary salt form of psilocin to enable practical delivery of psilocin directly, and in the case of E

    3/29/22 8:00:00 AM ET
    $SPKB
    Blank Checks
    Finance

    $SPKB
    SEC Filings

    View All

    SEC Form 15-12G filed by Silver Spike Acquisition Corp II

    15-12G - Silver Spike Acquisition Corp II (0001826435) (Filer)

    4/3/23 5:10:39 PM ET
    $SPKB
    Blank Checks
    Finance

    SEC Form 25-NSE filed by Silver Spike Acquisition Corp II

    25-NSE - Silver Spike Acquisition Corp II (0001826435) (Subject)

    3/24/23 4:10:50 PM ET
    $SPKB
    Blank Checks
    Finance

    Silver Spike Acquisition Corp II filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Silver Spike Acquisition Corp II (0001826435) (Filer)

    3/13/23 9:30:46 PM ET
    $SPKB
    Blank Checks
    Finance

    $SPKB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Silver Spike Acquisition Corp II

    SC 13G - Silver Spike Acquisition Corp II (0001826435) (Subject)

    2/14/23 1:58:15 PM ET
    $SPKB
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Silver Spike Acquisition Corp II (Amendment)

    SC 13G/A - Silver Spike Acquisition Corp II (0001826435) (Subject)

    2/14/23 8:26:46 AM ET
    $SPKB
    Blank Checks
    Finance

    SEC Form SC 13G/A filed by Silver Spike Acquisition Corp II (Amendment)

    SC 13G/A - Silver Spike Acquisition Corp II (0001826435) (Subject)

    2/14/23 6:06:05 AM ET
    $SPKB
    Blank Checks
    Finance